Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients

Journal of Clinical Investigation

Volumn 125, Issue 4, 2015, Pages 1752-1762

  Magalhaes, Isabelle ^a,b,c   Pingris, Karine ^a,b,c   Poitou, Christine ^d,e,f   Bessoles, Stéphanie ^g   Venteclef, Nicolas ^d,e   Kiaf, Badr ^a,b,c   Beaudoin, Lucie ^a,b,c   Da Silva, Jennifer ^a,b,c   Allatif, Omran ^d,e,f   Rossjohn, Jamie ^h,i   Kjer Nielsen, Lars ^j   McCluskey, James ^j   Ledoux, Séverine ^a,b,c,k   Genser, Laurent ^d,e,f   Torcivia, Adriana ^f   Soudais, Claire ^g   Lantz, Olivier ^g   Boitard, Christian ^a,b,c,l   Aron Wisnewsky, Judith ^d,e,f   Larger, Etienne ^a,b,c,l   Clément, Karine ^d,e,f   Lehuen, Agnès ^a,b,c,l   more..

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e Institute OfCardiometabolism and Nutrition   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g PSL RESEARCH UNIVERSITY   (France)

^h MONASH UNIVERSITY   (Australia)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^l Pitié Salpêtrière Hospital ^*  (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 17; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; CYTOKINE; LEPTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; CELL ACTIVATION; CELL DEATH; CELL METABOLISM; CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUCOSAL ASSOCIATED INVARIANT T CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BLOOD; BLOOD CELL; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE COUNT; NATURAL KILLER T CELL; OMENTUM; PATHOLOGY; POSTOPERATIVE PERIOD; SUBCUTANEOUS TISSUE;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; BLOOD CELLS; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-17; LEPTIN; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; OBESITY; OMENTUM; ORGAN SPECIFICITY; POSTOPERATIVE PERIOD; SUBCUTANEOUS TISSUE; T-LYMPHOCYTE SUBSETS;

EID: 84926318323     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78941     Document Type: Article

References (40)

1. Lynch L, O'Shea D, Winter DC, Geoghegan J, Doherty DG, O'Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol. 2009;39(7):1893-1901.
2. Lynch L, et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity. 2012;37(3):574-587.
3. Schipper HS, et al. Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest. 2012;122(9):3343-3354.
4. Dusseaux M, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood. 2011;117(4):1250-1259.
5. Tang XZ, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol. 2013;190(7):3142-3152.
6. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 2011;32(5):212-218.
7. Treiner E, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164-169.
8. Le Bourhis L, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. 2010;11(8):701-708.
9. Kjer-Nielsen L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717-723.
10. Patel O, et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun. 2013;4:2142.
11. Reantragoon R, et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med. 2013;210(11):2305-2320.
12. Birkinshaw RW, Kjer-Nielsen L, Eckle SBG, McCluskey J, Rossjohn J. MAITs, MR1 and vitamin B metabolites. Curr Opin Immunol. 2014;26:7-13.
13. Corbett AJ, et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature. 2014;509(7500):361-365.
14. Matafome P, Sena C, Seica R. Methylglyoxal, obesity, and diabetes. Endocrine. 2013;43(3):472-484.
15. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022-1023.
16. Cotillard A, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013;500(7464):585-588.
17. Qin J, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60.
18. Karlsson FH, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99-103.
19. Furet JP, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049-3057.
20. Zhang H, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365-2370.
21. Kong LC, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013;98(1):16-24.
22. Lee OJ, et al. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults. Exp Gerontol. 2014;49:47-54.
23. Grimaldi D, et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 2013;40(2):192-201.
24. Leeansyah E, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013;121(7):1124-1135.
25. Novak J, Dobrovolny J, Novakova L, Kozak T. The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in males and females of reproductive age. Scand J Immunol. 2014; 80(4):271-275.
26. Fernandez CS, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection [published online ahead of print October 28, 2014]. doi:10.1038/icb.2014.91.
27. Billerbeck E, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A. 2010;107(7):3006-3011.
28. Cosgrove C, et al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood. 2013;121(6):951-961.
29. Serriari NE, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol. 2014;176(2):266-274.
30. Wong EB, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One. 2013;8(12):e83474.
31. van der Waart AB, et al. Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation. PLoS One. 2012;7(12):e50896.
32. Ussher JE, et al. CD161 CD8 T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol. 2013;44(1):195-203.
33. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM. Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab. 2007;293(3):E656-E665.
34. Burcelin R, et al. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab. 2013;15(suppl 3):61-70.
35. Jia X, Chang T, Wilson TW, Wu L. Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1. PLoS One. 2012;7(5):e36610.
36. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41(1):36-48.
37. Nishimura S, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914-920.
38. Dalmas E, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94(2):450-458.
39. Abdennour M, et al. Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab. 2014;99(3):898-907.
40. Dalmas E, et al. T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63(6):1966-1977.